DPFS Resource Request (University of Glasgow)
DPFS 资源请求(格拉斯哥大学)
基本信息
- 批准号:G0801687/1
- 负责人:
- 金额:$ 30.68万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2009
- 资助国家:英国
- 起止时间:2009 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The development of new treatments for a range of diseases requires both an ability to understand the disease as well as an ability to take this understanding and to use it for the development of new therapies. We have been active in this area and have moved, in a number of disease areas, from basic research to therapies which are almost at the point of being of patient benefit. We now wish to develop these therapies further and to take them to the stage at which they will be accepted as being of sufficient value for further clinical trials. To do this we need the help of experts who will be involved in managing these sometimes very complex projects. We have 3 main disease areas that we are interested in: cancer, heart disease and inflammatory diseases such as diseases of joints and lungs. These experts will develop our projects and will ensure that their potential entry into clinical practice is carefully and efficiently handled. In addition, some of the therapeutics we are interested in are experimental and we are also requesting some items of equipment which will be important in helping us to assess the effectiveness of these therapies.
为一系列疾病开发新的治疗方法既需要了解疾病的能力,也需要了解这种理解并将其用于开发新疗法的能力。我们一直活跃在这一领域,并在许多疾病领域从基础研究转向几乎对患者有益的治疗。我们现在希望进一步开发这些疗法,并将其带到被接受为具有足够价值的阶段,以进行进一步的临床试验。要做到这一点,我们需要专家的帮助,他们将参与管理这些有时非常复杂的项目。我们有3个主要的疾病领域,我们感兴趣的:癌症,心脏病和炎症性疾病,如关节和肺部疾病。这些专家将开发我们的项目,并将确保他们进入临床实践的可能性得到仔细和有效的处理。此外,我们感兴趣的一些疗法是实验性的,我们还要求一些设备,这对帮助我们评估这些疗法的有效性很重要。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Iain McInnes其他文献
The DESTINIES Study: an online Delphi study to build international consensus on the medical conditions and procedures that confer immunosuppression and their respective COVID-19 risk profiles
DESTINIES 研究:一项在线德尔菲研究,旨在就赋予免疫抑制的医疗状况和程序及其各自的 COVID-19 风险概况达成国际共识
- DOI:
10.1016/j.eclinm.2025.103239 - 发表时间:
2025-05-01 - 期刊:
- 影响因子:10.000
- 作者:
Meredith Leston;José M. Ordóñez-Mena;Mark Joy;F.D Richard Hobbs;Simon de Lusignan;Benjamin W. Teh;Ingrid de Groot;Iain McInnes;Hana M. El Sahly;John Isaacs;Monique Andersson;Francois Raffi;Wei Shen Lim;Richard Conway;Stefan Siebert;Iain Buchan;Martin Underwood;David Lowe;Michael Hoerger;Christopher E.M. Griffiths;Lennard Y.W. Lee - 通讯作者:
Lennard Y.W. Lee
Validated methods for assessment of subclinical atherosclerosis in rheumatology
风湿病中亚临床动脉粥样硬化评估的验证方法
- DOI:
10.1038/nrrheum.2012.16 - 发表时间:
2012-02-21 - 期刊:
- 影响因子:32.700
- 作者:
György Kerekes;Pál Soltész;Michael T. Nurmohamed;Miguel A. Gonzalez-Gay;Maurizio Turiel;Edit Végh;Yehuda Shoenfeld;Iain McInnes;Zoltán Szekanecz - 通讯作者:
Zoltán Szekanecz
Expert consensus statement on the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: 2024 update
关于使用Janus激酶抑制剂治疗免疫介导性炎症疾病的专家共识声明:2024年更新版
- DOI:
10.1016/j.ard.2025.01.032 - 发表时间:
2025-05-01 - 期刊:
- 影响因子:20.600
- 作者:
Peter Nash;Andreas Kerschbaumer;Victoria Konzett;Daniel Aletaha;Thomas Dörner;Roy Fleischmann;Iain McInnes;Jette Primdahl;Naveed Sattar;Yoshiya Tanaka;Michael Trauner;Kevin Winthrop;Maarten de Wit;Johan Askling;Xenofon Baraliakos;Wolf-Henning Boehncke;Paul Emery;Laure Gossec;John D. Isaacs;Maria Krauth;Josef S. Smolen - 通讯作者:
Josef S. Smolen
Cure as a treatment target in rheumatoid arthritis and systemic sclerosis—achievable aim or mission impossible? FOREUM stimulates new industry-academia collaboration
在类风湿关节炎和系统性硬化症中,治愈作为治疗目标——可实现的目标还是不可能完成的任务?欧洲风湿病联盟(FOREUM可能是EULAR的笔误,EULAR为欧洲抗风湿病联盟)促进了新的产学研合作
- DOI:
10.1136/ard-2024-226772 - 发表时间:
2025-02-01 - 期刊:
- 影响因子:20.600
- 作者:
Kenneth Frank Baker;Julia Spierings;Martin Brom;Timothy Radstake;Emma Smith;Roberta Weiss;Gerd R. Burmester;Johannes WJ Bijlsma;Iain McInnes;Kenneth Baker;Rik Lories;Costantino Pitzalis;Jörg HW Distler;Gerd Burmester;Andrew P Cope;Oliver Distler;Julia Spierings;Anna Maria Hoffmann-Vold;Tim Radstake;Christian A Goess;Richard Vesely - 通讯作者:
Richard Vesely
Iain McInnes的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Iain McInnes', 18)}}的其他基金
Optimising Vaccine Efficacy in Multi-Disease Patient Cohorts with SARS-CoV-2 vaccine failure (OCTAVE-DUO)
优化 SARS-CoV-2 疫苗失败的多疾病患者群体的疫苗功效 (OCTAVE-DUO)
- 批准号:
MR/W020653/1 - 财政年份:2021
- 资助金额:
$ 30.68万 - 项目类别:
Research Grant
MICA: Immune-Mediated Inflammatory Disease Biobanks in the UK (IMIDBio-UK)
MICA:英国免疫介导的炎症性疾病生物库 (IMIDBio-UK)
- 批准号:
MR/R014191/1 - 财政年份:2017
- 资助金额:
$ 30.68万 - 项目类别:
Research Grant
Scottish Clinical Pharmacology & Pathology Programme (SCP3)
苏格兰临床药理学
- 批准号:
G1000419/1 - 财政年份:2011
- 资助金额:
$ 30.68万 - 项目类别:
Fellowship
相似海外基金
IRIS Digital Asset - Resource Request to create a FAIR data archive
IRIS 数字资产 - 创建 FAIR 数据档案的资源请求
- 批准号:
ST/Y004655/1 - 财政年份:2023
- 资助金额:
$ 30.68万 - 项目类别:
Research Grant
IDP13 Project 103699 request for for additional resource costs
IDP13 项目 103699 请求额外资源费用
- 批准号:
73701 - 财政年份:2020
- 资助金额:
$ 30.68万 - 项目类别:
Feasibility Studies
FY22. TO5. NIDA PHARMACOKINETIC ANALYSIS RESOURCE CENTER. NIDA REF. NO. N01DA-19-8947. POP EXTENSION REQUEST.
22 财年。
- 批准号:
10721037 - 财政年份:2019
- 资助金额:
$ 30.68万 - 项目类别:
DPFS resource request (University of Oxford) development pathway director
DPFS资源请求(牛津大学)发展路径总监
- 批准号:
G0801678/1 - 财政年份:2011
- 资助金额:
$ 30.68万 - 项目类别:
Research Grant
DPFS Resource Request (University of Birmingham)
DPFS 资源请求(伯明翰大学)
- 批准号:
G0801681/1 - 财政年份:2009
- 资助金额:
$ 30.68万 - 项目类别:
Research Grant
QUESTION OR TRAINING REQUEST FOR THE YEAST RESOURCE CENTER
对酵母资源中心的问题或培训请求
- 批准号:
7957705 - 财政年份:2009
- 资助金额:
$ 30.68万 - 项目类别:
QUESTION OR TRAINING REQUEST FOR THE YEAST RESOURCE CENTER
对酵母资源中心的问题或培训请求
- 批准号:
7957699 - 财政年份:2009
- 资助金额:
$ 30.68万 - 项目类别:
QUESTION OR TRAINING REQUEST FOR THE YEAST RESOURCE CENTER
对酵母资源中心的问题或培训请求
- 批准号:
7957830 - 财政年份:2009
- 资助金额:
$ 30.68万 - 项目类别:
DPFS Resource Request (Cardiff University/Bristol University SARTRE):A core protein production facility
DPFS资源请求(卡迪夫大学/布里斯托大学SARTRE):核心蛋白质生产设施
- 批准号:
G0801676/1 - 财政年份:2009
- 资助金额:
$ 30.68万 - 项目类别:
Research Grant
DPFS Resource request (University of Sheffield) A High-content high-throughput Screening Facility in an Academic Setting
DPFS 资源请求(谢菲尔德大学)学术环境中的高内容高通量筛选设施
- 批准号:
G0801680/1 - 财政年份:2009
- 资助金额:
$ 30.68万 - 项目类别:
Research Grant